We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Liberty Global Class C
LBTYK
$3.57B
| $456K | ﹤0.01% |
22,371
+597
| +3% | +$12.6K |
|
|
OBE
1277
Obsidian Energy
OBE
$678M
| $455K | ﹤0.01% |
71,292
+5,836
| +9% | +$38K |
|
1278
Twist Bioscience
TWST
$6.03B
| $451K | ﹤0.01% |
29,874
| – | – |
|
|
VERV
1279
DELISTED
Verve Therapeutics
VERV
| $448K | ﹤0.01% |
31,062
+6,200
| +25% | +$121K |
|
1280
Crinetics Pharmaceuticals
CRNX
$8.87B
| $443K | ﹤0.01% |
+27,600
| New | +$511K |
|
1281
Banc of California
BANC
$3.04B
| $442K | ﹤0.01% |
35,300
+25,200
| +250% | +$407K |
|
1282
Sana Biotechnology
SANA
$868M
| $439K | ﹤0.01% |
134,226
| – | – |
|
1283
Lindsay Corp
LNN
$1.15B
| $438K | ﹤0.01% |
2,900
-4,400
| -60% | -$665K |
|
1284
Talos Energy
TALO
$2.48B
| $438K | ﹤0.01% |
29,500
+10,700
| +57% | +$184K |
|
1285
PC Connection
CNXN
$2.16B
| $436K | ﹤0.01% |
9,700
+4,200
| +76% | +$192K |
|
1286
Titan International
TWI
$468M
| $433K | ﹤0.01% |
41,300
+21,300
| +107% | +$302K |
|
1287
Enanta Pharmaceuticals
ENTA
$367M
| $433K | ﹤0.01% |
10,700
| – | – |
|
1288
Zillow
Z
$7.97B
| $432K | ﹤0.01% |
9,725
-200
| -2% | -$8.5K |
|
1289
Lumen
LUMN
$6.6B
| $432K | ﹤0.01% |
163,151
-244,919
| -60% | -$988K |
|
1290
Chewy
CHWY
$9.47B
| $432K | ﹤0.01% |
11,564
+352
| +3% | +$14.6K |
|
1291
Monarch Casino & Resort
MCRI
$2.22B
| $430K | ﹤0.01% |
5,800
+1,600
| +38% | +$122K |
|
1292
Red Robin
RRGB
$146M
| $429K | ﹤0.01% |
29,926
| – | – |
|
|
TSVT
1293
DELISTED
2seventy bio
TSVT
| $428K | ﹤0.01% |
+42,000
| New | +$480K |
|
|
BLFY
1294
DELISTED
Blue Foundry Bancorp
BLFY
| $425K | ﹤0.01% |
44,650
| – | – |
|
1295
Lyell Immunopharma
LYEL
$316M
| $424K | ﹤0.01% |
8,984
| – | – |
|
1296
Voyager Therapeutics
VYGR
$179M
| $419K | ﹤0.01% |
54,300
| – | – |
|
|
BCPC
1297
Balchem Corp
BCPC
$5.54B
| $417K | ﹤0.01% |
3,300
| – | – |
|
|
TBRG
1298
DELISTED
TruBridge
TBRG
| $414K | ﹤0.01% |
13,700
+1,200
| +10% | +$35K |
|
|
AZPN
1299
DELISTED
Aspen Technology Inc
AZPN
| $410K | ﹤0.01% |
1,791
-229
| -11% | -$47.5K |
|
1300
Ethan Allen Interiors
ETD
$589M
| $409K | ﹤0.01% |
+14,900
| New | +$423K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.